MoneyWorks4Me

The sales slipped to Rs. 1138.51 millions for the June 2024 quarter as against Rs. 1485.36 millions during the year-ago period.Net Profit witnessed a 1096.10% growth almost the double from Rs. 23.61 millions to Rs. 282.40  millions  of same quarter last year.Operating profit surged to 431.52 millions from the corresponding previous quarter of 240.27 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 1138.51 1485.36 -23.35 1138.51 1485.36 -23.35 5022.48 4109.58 22.21
Other Income 399.31 56.30 609.25 399.31 56.30 609.25 579.93 118.54 389.23
PBIDT 431.52 240.27 79.60 431.52 240.27 79.60 1065.08 538.87 97.65
Interest 95.43 149.45 -36.15 95.43 149.45 -36.15 629.36 597.62 5.31
PBDT 336.09 90.82 270.06 336.09 90.82 270.06 435.72 547.04 -20.35
Depreciation 53.69 67.21 -20.12 53.69 67.21 -20.12 271.07 286.68 -5.45
PBT 282.40 23.61 1096.10 282.40 23.61 1096.10 164.65 260.36 -36.76
TAX 0.00 0.00 0.00 0.00 0.00 0.00 22.32 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 282.40 23.61 1096.10 282.40 23.61 1096.10 142.33 260.36 -45.33
Equity 108.33 108.33 0.00 108.33 108.33 0.00 108.33 108.33 0.00
PBIDTM(%) 37.90 16.18 134.31 37.90 16.18 134.31 21.21 13.11 61.73
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..